Author

Yingke Liang

Institut du cancer Rosalind & Morris GoodmanPrimary ORCID profile (0000-0001-6247-8294 · 3 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Yingke LiangiD3 papers · University of Toronto

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Organism:chicken / avian· 1 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Bhushan Nagar· 1 shared Cristina Fernandez· 1 shared Cynthia Y. Feng· 1 shared Daina Zofija AvizonisiD· 1 shared David M. SharoniD· 1 shared Faiz Hussain· 1 shared Heidi Gytz· 1 shared Isabelle Gamache· 1 shared

Activity by Year

2018-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Bhushan Nagar

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Viral inhibition of the anaphase promoting complex enhances replication by elevating nucleotide pools

Owen J. Chen, Cynthia Y. Feng, Paola Blanchette, Reese Jalal Ladak, Maximilian Crosby, Mariana De Sa Tavares Russo, Yilin Wang, Cristina Fernandez, Yingke Liang, David M. Sharon, Mohamed Moustafa-Kamal, Isabelle Gamache, Nahum Sonenberg, Daina Zofija Avizonis, Jose G. Teodoro

This paper shows that viral inhibition of the APC/C enhances replication by increasing nucleotide pools through stabilization of biosynthesis enzymes.

PLoS Pathogens · Aug 12, 2026Peer-reviewedMicrobiology

Receptor Mediated Delivery of Cas9-Nanobody Induces Cisplatin Synthetic Dose Sensitivity

Philip J. R Roche, Heidi Gytz, Faiz Hussain, Yingke Liang, Nick Stub Laursen, Kasper R. Andersen, Bhushan Nagar, Uri David Akavia

This study demonstrates receptor-mediated delivery of Cas9-Nanobody to A549 cells, enhancing cisplatin sensitivity through synthetic dose lethality.

bioRxiv · Aug 9, 2018 · PreprintBiochemistry